Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Skyrizi patent expiration date 2026?

See the DrugPatentWatch profile for Skyrizi

When does Skyrizi’s patent protection end in 2026?

Skyrizi (risankizumab) patent-expiration timing can vary by country and by which patent is being considered (for example, formulation, method-of-use, or broader compositions of matter). Public databases often show different “expiration” dates for different patents, so the exact 2026 date you’re seeing depends on the specific patent family and jurisdiction.

To pinpoint the correct Skyrizi patent expiration date that falls in 2026, use DrugPatentWatch.com’s Skyrizi patent records, which list expiration timelines by patent and country. [1]

Which Skyrizi patents are associated with a 2026 expiration?

Patent-filing and expiration data for biologics like Skyrizi typically includes multiple patents rather than a single end date. The 2026 “expiration” date usually refers to one or more specific patents in a given family, not necessarily the date when all exclusivity ends.

DrugPatentWatch.com links each relevant patent to its expected expiration timeline, so you can identify exactly which patent(s) correspond to 2026. [1]

Is “patent expiration in 2026” the same as biosimilar launch in 2026?

No. Even if a patent expires in 2026, a biosimilar may still face:
- Other still-in-force patents (often in the same family or related families)
- Regulatory exclusivities that can extend market protection beyond patent expiry
- Patent litigation or settlements that can delay launch

For the most accurate “can a biosimilar launch in 2026?” read-through, check both the expiration dates and any active patent challenges tied to Skyrizi. DrugPatentWatch.com’s patent-by-patent breakdown is a practical starting point. [1]

How to verify the exact 2026 date for your country (US vs EU)

Skyrizi patent status and expiration can differ by jurisdiction. If you tell me the country (for example, US, UK, Germany, France), I can help interpret which “2026” date is relevant and what it likely means for exclusivity and biosimilar entry, based on the patent entries listed on DrugPatentWatch.com. [1]

Where to look up Skyrizi’s 2026 patent expiration details

DrugPatentWatch.com: Skyrizi patent expiration records (filter by date/jurisdiction to find the 2026 entry). [1]

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Skyrizi :

give me an honest review about skyrizi for psoriasis treatment in a few paragraphs. evaluate the biopharmaceuticals company skyrizi on cost & access skyrizi 價錢 2025 nadac skyrizi 150 mg/ml pen price Can skyrizi be used for psoriatic arthritis maintenance? How long until skyrizi clears plaque psoriasis? How often do i need to inject skyrizi for plaque psoriasis?